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CASE REPORT
A 55-year-old male presented at the Oral Medicine Clinic 
of the University of the Western Cape, Oral Health Centre, 
Tygerberg Campus, for the evaluation of a persistent white 
patch on his right edentulous mandibular ridge. He had 
been referred from the Prosthodontics Clinic where he 
was seen for complete denture rehabilitation. The patient 
had no significant medical history and informed us that 
he had been smoking marijuana five times a day for more 
than twenty years and consumed alcohol occassionally. 
He had never worn a dental prosthesis and did not use 
tobacco in any form.
Extra-oral examination revealed bilateral submandibular 
lymphadenopathy and asymptomatic clicking of both 
temporomandibular joints during jaw opening. Intraoral 
examination showed completely edentulous upper and 
lower arches with a healing extraction socket in the posterior 
third quadrant. An asymptomatic, white homogenous plaque 
measuring 3x5mm, which could not be wiped off, was 
present on the crest of the right mandibular ridge (Figure 1). 
Due to the small size of the lesion, an excisional biopsy 
was performed under local anaesthesia. Following 
the surgical procedure, the patient was prescribed 
0.2% chlorhexidine digluconate oral rinse and 500mg 
Paracetamol four times daily.
Histological examination of the excised white plaque 
disclosed a fragment of squamous mucosa with 
acanthosis and hyperkeratosis (Figure 2). The sub-
epithelial connective tissue was densely collagenized 
and showed a mild chronic inflammatory cell infiltrate. 
There was no evidence of dysplasia or malignancy in the 
histological sections examined. The Periodic Acid Schiff 
(PAS) stain was negative for fungal elements.
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ACRONYMS
LBC:  liquid based cytology 
PMDs:   potentially malignant disorders 
TB:  Toluidine blue 
WHO:  World Health Organization  
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Figure 1: A small homogenous white plaque on the right mandibular 
alveolar ridge. 
Figure 2: The low power photomicrograph of the lesion seen in Figure 1 
shows hyperparakeratosis of the surface epithelium (H & E, x 40). The ﬁbrous 
connective tissue stroma exhibits mild chronic inﬂammation.. 
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Evaluation of the biopsy site after two weeks showed complete 
resolution of the lesion. Based on the clinical and microscopic 
features, a diagnosis of non-dysplastic marijuana-induced oral 
leukoplakia was established. The patient was advised to stop 
smoking marijuana since there is a risk of possible malignant 
change. He was instructed to return to the clinic in six months 
for his periodic follow up visit.
 
DISCUSSION 
Oral white lesions reflect many different diseases and 
pathological changes. Leukoplakia was first defined by 
the World Health Organization (WHO) in 19781 as a white 
patch or plaque which cannot otherwise be characterized 
clinically or pathologically as any other disease. A revised 
definition was proposed in 2007 by the WHO Collaborating 
Centre for Oral Cancer and Pre-cancer Working Group, 
in which leukoplakia was defined as “a white plaque of 
questionable risk, having excluded other known diseases 
or disorders, that carry no increased risk for malignant 
transformation.”2
 
Worldwide, the estimated prevalence of oral leukoplakia is 
1.7% to 2.7% for all age groups.3 Between 16% and 62% 
of oral squamous carcinomas are reported to arise from 
an area of oral leukoplakia,4 emphasizing the need for 
routine oral screening programs and regular monitoring of 
high risk individuals.
Globally, leukoplakias are reportedly diagnosed after the 
fourth decade of life and are six times more common 
among smokers than non-smokers.2 A clinical diagnosis 
of oral leukoplakia is made when a predominantly white 
lesion cannot be clearly diagnosed as any other disease or 
disorder of the oral mucosa. A biopsy is mandatory, since 
the differential diagnosis of leukoplakia is broad and may 
include oral lichen planus, pseudomembranous candidiasis, 
chemical injury, frictional keratosis, oral lichen planus, oral 
epithelial dysplasia and squamous cell carcinoma.2
The most common aetiologic factor for leukoplakia 
is tobacco smoking, cessation of which may lead to 
regression or total disappearance of oral leukoplakia.5 A 
definite link between marijuana use and oral leukoplakia 
has not been established. Most studies of oral leukoplakia 
have focused on the role of tobacco as an aetiologic factor, 
since tobacco smoking is a more socially acceptable 
behaviour. In addition, the legal use of marijuana is 
restricted to certain countries.
 
More recently, marijuana use has been legalized in many 
states in America and some European countries. An 
American study found that marijuana use among adults 
in the United States has doubled in the last decade.6 
In South Africa, the use of drugs such as marijuana, 
“tik” (metamphetamine) and cocaine is twice the global 
average and the highest in Africa.7
 
Marijuana is derived from the macerated flowers of 
Cannabis satava and contains the toxic compound 
A9 tetrahydrocannabinol (THC), a cannabinoid, which 
constitutes 1-6% m/v of the total weight of the plant 
flowers.8 In addition, more than 60 other cannabinoids have 
been identified in cannabis. When cannabis is smoked as 
marijuana, the resultant heat leads to aromatization of 
the cannabinoids and to carcinogenic substances such 
as polycyclic aromatic hydrocarbons, benzo[a]-pyrene, 
phenols, phytosterols, acids and terpenes, which are 
detectable in marijuana smoke.9  Marijuana thus carries 
the same carcinogens found in cigarette smoke and these 
carcinogens are known to cause DNA damage, which 
could potentially lead to malignant transformation.
In general, leukoplakias with dysplasia pose a higher 
risk for malignant transformation, compared with non-
dysplastic leukoplakias.5,10 Several molecular biomarkers 
have been proposed, but currently, no single biomarker 
can accurately predict the potential for malignant 
transformation.11
 
Currently, a range of non-invasive adjunctive diagnostic 
methodologies are available to screen oral potentially 
malignant disorders (PMDs), such as oral leukoplakias. 
These include vital staining techniques (using toluidine 
blue/tolonium chloride/ lugol’s iodine),12 light based 
detection systems13 and exfoliative cytology.14
Toluidine blue (TB) is a basic thiazine metachromatic dye, 
which stains tissues rich in nucleic acids because of its 
high affinity for acidic tissue components. Both dysplastic 
and neoplastic cells contain more nucleic acids than 
normal cells. TB-stained tissue may appear dark or pale 
royal blue and has been used for many years as an aid 
for the screening and post-surgical management of PMDs 
and oral cancer.15,16 It has been reported that TB staining 
could assist in early detection of oral cancer compared with 
conventional visual inspection alone.17 A systematic review 
revealed that TB has a sensitivity of 84% and a specificity of 
70%  and can be a valuable diagnostic tool in screening of 
large group of patients.18 A high percentage of false positive 
results have been associated with TB due to its ability to 
stain cells in benign hyperplastic and inflammatory lesions, 
which also contain large quantities of nucleic acids.19
 
A number of light-based detection systems such as 
Vizilite, Vizilite plus, Microlux DL, narrow mission tissue 
fluoroscence and the Velscope, have been developed. 
The principle of these light-based detection systems 
is based on the fact that mucosal tissues undergoing 
inflammatory, abnormal metabolic or structural changes 
have different absorbance and reflectance profiles when 
exposed to various forms of light sources, enabling the 
differentiation of oral mucosal abnormalities.20 ViziLite 
shows high sensitivity (77%) and low specificity (28%)20 
in detecting oral PMDs and oral cancer.21 Some studies 
found that ViziLite could not differentiate between keratotic 
or inflammatory oral PMDs and oral cancer.22,23 The Vizilite 
Plus combines the features of the Vizilite and TB and can 
further delineate ViziLite-positive lesions, thus improving 
its specificity as a diagnostic tool.24
 
Exfoliative cytology is a quick and simple procedure 
based on a relatively atraumatic semi-invasive technique, 
allowing for the collection of a rich concentrate of cells 
over a wider area than selective tissue biopsy and is ideal 
for use in large leukoplakic lesions. Recent cytologic 
techniques, such as liquid based cytology (LBC), have 
further improved the quality of oral cytologic smears.25 
With LBC; the residual liquid based material can be used 
for immunocytochemistry and molecular testing.
Currently, none of the adjunctive diagnostic tests could 
be recommended as a replacement for scalpel biopsy 
and histopathological assessment.18 However, the use 
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of adjunctive tests (e.g. the use of Velscope to guide 
biopsies, and exfoliative cytology in large leukoplakic 
lesions), can further improve the overall accuracy of the 
histological assessment. 
CONCLUSION
The current case report describes a unique case of 
marijuana-induced oral leukoplakia. With the increased 
use of marijuana in South Africa, a rise in marijuana –
induced oral leukoplakic lesions may be expected. 
Dentists and oral hygienists should be aware of the 
possibility of marijuana use when confronted with oral 
leukoplakic lesions and their potentially malignant nature. 
The use of adjunctive screening tests may further improve 
the overall accuracy of histological examination.  
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